Coverage Initiated by HC Wainwright for Gossamer Bio (NASDAQ:GOSS)

0
27

Stock analysts at HC Wainwright initiated coverage on shares of  Gossamer Bio (NASDAQ:GOSS) in a report issued on Monday. The brokerage set a Buy rating on the Medical stock. A price-to-earnings ratio of #N/A and a beta of #N/A. Gossamer Bio has a twelve month low $7.52 of  and a twelve month high of $27.15.

Shares of Gossamer Bio traded up $0.34 on Monday, reaching $12.83. 123741 shares of the stock traded hands, compared to its average volume of 979203. Shares of Gossamer Bio were trading at $12.83 on Monday mid-day. The firm’s 50 day moving average is $$12.97 and its 200 day moving average is $15.58.Gossamer Bio  has a 12 month low of $12.58 and a 12 month high of $27.15. While on yearly highs and lows, Gossamer Bio’s today has traded high as $13.00 and has touched $12.58 on the downward trend. See More Analyst Rating at: RATING

Gossamer Bio Earnings and What to expect: 

Gossamer Bio last posted its quarterly earnings results on May 12th, 2020. The reported ($0.87) EPS for the quarter, missing the consensus estimate of ($0.80) by $0.07. Gossamer Bio has generated ($3.29) earnings per share over the last year. Gossamer Bio has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, August 13th, 2020 based off prior year’s report dates.

Earnings for Gossamer Bio are expected to decrease in the coming year, from ($3.38) to ($3.49) per share. The P/E ratio of Gossamer Bio is -3.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Gossamer Bio is -3.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Gossamer Bio has a P/B Ratio of 2.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 23.30%
  • On 6/23/2020 CFO Bryan Giraudo Buy 2,000 at average share price of $12.96 which equates to $25,920.00 in money value.
  • On 12/30/2019 Insider Jakob Dupont Sell 40,000 at average price of  $15.00 with total value of : Not Data Available
  • On 12/27/2019 Insider Jakob Dupont Sell 1,994 at average price of  $15.81 with total value of : $31,525.14

Analyt at HC Wainwright other ratings :

Latest rating for Gossamer Bio by other brokers:

  • 6/29/2020 – Chiasma had its price target raised by analysts at HC Wainwright from $10.00 to $11.00. They now have a “buy” rating on the stock.
  • 6/29/2020 – Novavax had its price target raised by analysts at HC Wainwright from $50.00 to $101.00. They now have a “buy” rating on the stock.
  • 6/29/2020 – Arena Pharmaceuticals is now covered by analysts at HC Wainwright. They set a “buy” rating and a $90.00 price target on the stock.
  • 6/29/2020 – Inovio Pharmaceuticals was downgraded by analysts at HC Wainwright from a “buy” rating to a “neutral” rating.

Gossamer Bio (NASDAQ:GOSS) Moving Average Technical Analysis

5 day Moving Average is $12.69 And 5 day price change is -$0.10 (-0.78%)  with average volume for 5 day average is 763,803. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $12.46 and 20 day price change is $0.69 (5.70%) and average 20 day moving volume is 660,291. 50 day moving average is $12.97  and 50 day price change is $1.28 ( 11.12%)  and with average volume for 50 days is : 735,776. 200 day moving average is $15.58  and 200 day price change is -$9.09 (-41.54%)  and with average volume for 200 days is : 600,720.

See More Analyst Rating at: RATING